Fontana C, Widmalm G. Primary structure of glycans by NMR Spectroscopy. Chem Rev. 2023;123:1040–102.
Article CAS PubMed PubMed Central Google Scholar
Widmalm G. Glycan shape, motions, and interactions explored by NMR Spectroscopy. JACS Au. 2024;4:20–39.
Article CAS PubMed PubMed Central Google Scholar
Helenius A, Aebi M. Intracellular functions of N-linked glycans. Science. 2001;291:2364–9.
Article CAS PubMed Google Scholar
Breitling J, Aebi M. N-linked protein glycosylation in the endoplasmic reticulum. Cold Spring Harb Perspect Biol. 2013;5:a013359.
Article PubMed PubMed Central Google Scholar
Reily C, Stewart TJ, Renfrow MB, Novak J. Glycosylation in health and disease. Nat Rev Nephrol. 2019;15:346–66.
Article PubMed PubMed Central Google Scholar
Varki A. Biological roles of glycans. Glycobiology. 2017;27:3–49.
Article CAS PubMed Google Scholar
Jaeken J. Congenital disorders of glycosylation. Handb Clin Neurol. 2013;113:1737–43.
Article CAS PubMed Google Scholar
Boyer SW, Johnsen C, Morava E. Nutrition interventions in congenital disorders of glycosylation. Trends Mol Med. 2022;28:463–81.
Article CAS PubMed PubMed Central Google Scholar
Francisco R, Pascoal C, Marques-da-Silva D, Brasil S, Pimentel-Santos FM, Altassan R, et al. New insights into immunological involvement in Congenital Disorders of Glycosylation (CDG) from a people-centric approach. J Clin Med. 2020;9:2092.
Article CAS PubMed PubMed Central Google Scholar
Schollen E, Kjaergaard S, Legius E, Schwartz M, Matthijs G. Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia). Eur J Hum Genet. 2000;8:367–71.
Article CAS PubMed Google Scholar
Altassan R, Péanne R, Jaeken J, Barone R, Bidet M, Borgel D, et al. International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up. J Inherit Metab Dis. 2019;42:5–28.
Article CAS PubMed Google Scholar
Sharma V, Ichikawa M, Freeze HH. Mannose metabolism: more than meets the eye. Biochem Biophys Res Commun. 2014;453:220–8.
Article CAS PubMed PubMed Central Google Scholar
Matthijs G, Schollen E, Bjursell C, Erlandson A, Freeze H, Imtiaz F, et al. Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia). Hum Mutat. 2000;16:386–94.
Article CAS PubMed Google Scholar
Gámez A, Serrano M, Gallego D, Vilas A, Pérez B. New and potential strategies for the treatment of PMM2-CDG. Biochim Biophys Acta Gen Subj. 2020;1864:129686.
Altassan R, Witters P, Saifudeen Z, Quelhas D, Jaeken J, Levtchenko E, et al. Renal involvement in PMM2-CDG, a mini-review. Mol Genet Metab. 2018;123:292–6.
Article CAS PubMed Google Scholar
Muthusamy K, Perez-Ortiz JM, Ligezka AN, Altassan R, Johnsen C, Schultz MJ, et al. Neurological manifestations in PMM2-congenital disorders of glycosylation (PMM2-CDG): Insights into clinico-radiological characteristics, recommendations for follow-up, and future directions. Genet Med. 2024;26:101027.
Article CAS PubMed Google Scholar
Ligezka AN, Budhraja R, Nishiyama Y, Fiesel FC, Preston G, Edmondson A, et al. Interplay of Impaired Cellular Bioenergetics and Autophagy in PMM2-CDG. Genes. 2023;14:1585.
Article CAS PubMed PubMed Central Google Scholar
Gallego D, Serrano M, Cordoba-Caballero J, Gámez A, Seoane P, Perkins JR, et al. Transcriptomic analysis identifies dysregulated pathways and therapeutic targets in PMM2-CDG. Biochim Biophys Acta Mol Basis Dis. 2024;1870:167163.
Article CAS PubMed Google Scholar
Radenkovic S, Ligezka AN, Mokashi SS, Driesen K, Dukes-Rimsky L, Preston G, et al. Tracer metabolomics reveals the role of aldose reductase in glycosylation. Cell Rep Med. 2023;4:101056.
Article CAS PubMed PubMed Central Google Scholar
Vilas A, Yuste-Checa P, Gallego D, Desviat LR, Ugarte M, Pérez-Cerda C, et al. Proteostasis regulators as potential rescuers of PMM2 activity. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165777.
Article CAS PubMed Google Scholar
Budhraja R, Radenkovic S, Jain A, Muffels IJJ, Ismaili MHA, Kozicz T, et al. Liposome-encapsulated mannose-1-phosphate therapy improves global N-glycosylation in different congenital disorders of glycosylation. Mol Genet Metab. 2024;142:108487.
Article CAS PubMed Google Scholar
Schneider A, Thiel C, Rindermann J, DeRossi C, Popovici D, Hoffmann GF, et al. Successful prenatal mannose treatment for congenital disorder of glycosylation-Ia in mice. Nat Med. 2011;18:71–3.
Thiel C, Lübke T, Matthijs G, von Figura K, Körner C. Targeted disruption of the mouse phosphomannomutase 2 gene causes early embryonic lethality. Mol Cell Biol. 2006;26:5615–20.
Article CAS PubMed PubMed Central Google Scholar
Chan B, Clasquin M, Smolen GA, Histen G, Powe J, Chen Y, et al. A mouse model of a human congenital disorder of glycosylation caused by loss of PMM2. Hum Mol Genet. 2016;25:2182–93.
Article CAS PubMed PubMed Central Google Scholar
Hayashi S, McMahon AP. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol. 2002;244:305–18.
Article CAS PubMed Google Scholar
Balakrishnan B, Yan X, McCue MD, Bellagamba O, Guo A, Winkler F, et al. Whole-body galactose oxidation as a robust functional assay to assess the efficacy of gene-based therapies in a mouse model of Galactosemia. Mol Ther Methods Clin Dev. 2024;32:101191.
Article CAS PubMed PubMed Central Google Scholar
Truett GE, Heeger P, Mynatt RL, Truett AA, Walker JA, Warman ML. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques. 2000;29:52.
Article CAS PubMed Google Scholar
Balakrishnan B, Verheijen J, Lupo A, Raymond K, Turgeon C, Yang Y, et al. A novel phosphoglucomutase-deficient mouse model reveals aberrant glycosylation and early embryonic lethality. J Inherit Metab Dis. 2019;42:998–1007.
Article CAS PubMed PubMed Central Google Scholar
Guyenet SJ, Furrer SA, Damian VM, Baughan TD, La Spada AR, Garden GA A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia. Journal of visualized experiments : JoVE. 2010:1787.
Kim BW, Jeong KH, Kim JH, Jin M, Kim JH, Lee MG, et al. Pathogenic upregulation of Glial Lipocalin-2 in the Parkinsonian Dopaminergic System. J Neurosci. 2016;36:5608–22.
Article CAS PubMed PubMed Central Google Scholar
Koitabashi N, Bedja D, Zaiman AL, Pinto YM, Zhang M, Gabrielson KL, et al. Avoidance of
Comments (0)